A New Editor—Building on a
Tradition of Excellence
It is with great pleasure that I assume the position of Editor-in-Chief of Advances in Pulmonary Hypertension. The journal is
now in its 6th year of helping physicians by informing them of
important trends in caring for patients with pulmonary hypertension.
For the past 2 years, Vallerie V. McLaughlin, MD, as
Editor-in-Chief in 2005 and 2006, has shown me how to
orchestrate the journal into a state-of-the art reference for
pulmonary hypertension that has become a stunning success,
with a circulation that has grown to more than 36,000. From her timely topic
selections to her meticulous, watchful eye, Dr McLaughlin has set the stage for
the journal’s continued success and has provided us with healthy momentum
to this end. An enormous credit goes to the journal’s founding editor, Victor F.
Tapson, MD. Dr Tapson’s efforts in launching a journal with critical reviews of
the newest areas of diagnosis and treatments for patients with pulmonary
hypertension heralded a successful 3-year tenure, a tradition that continues
today.
In this, the 21st issue of the journal, Roxana Sulica, MD, has taken the role
of lead editor, overseeing three detailed reviews of the associations between hemoglobinopathies and pulmonary hypertension. The complex pathophysiology
is evident in the review by Drs Gladwin and Kato. The clinical aspects of sicklecell-
associated pulmonary hypertension are critically examined by Drs Machado
and Castro, and a look into the clinical facets of thallasemia-associated
pulmonary hypertension is provided by Drs Morris, Vichinsky, and Singer. These
reviews remind us of the broad scope of conditions that contribute to a seemingly
increasing prevalence of pulmonary vascular diseases that is being recognized
throughout the world. Finally, an expert roundtable discusses the similarities
and differences between pulmonary hypertension associated with hemoglobinopathies
and pulmonary arterial hypertension in its classic definition,
clearly calling attention to the need for therapeutic clinical trials.
I hope that you will enjoy this timely issue of Advances in Pulmonary
Hypertension, the only journal of its kind, and share in the rewards of future
issues.
Profiles in Pulmonary Hypertension:Gérald Simonneau, MD:
Pioneer, Mentor, and a Driving Force
in Pulmonary Hypertension Research
for His Colleagues (PDF)
When a physician’s curriculum vitae
totals 232 articles that he has either
authored or coauthored, there is little
doubt that he ranks high in the pantheon
of pulmonary hypertension
researchers. This is just the beginning
of Dr Gérald Simonneau’s credentials
as a world-class physician and
investigator, one of the most widely
published authors in the fields of
pulmonary hypertension, pulmonary vascular diseases,
and pneumology.
Hemolysis-Associated Endothelial Dysfunction and
Pulmonary Hypertension, an Emerging Cause of
Death in the Hemoglobinopathies (PDF)
Medical advances in the management of patients with sickle
cell disease (SCD), thalassemia, and other hemolytic anemias
have led to significant increases in life expectancy.
Improved public health with neonatal genetic screening,
parental and patient education, advances in red cell transfusion
medicine safety, aggressive iron chelation therapy,
penicillin prophylaxis for children under 6 years of age,
immunization, and hydroxyurea therapy have all likely contributed
to this effect on longevity. Now, as a generation
of patients with SCD and thalassemia ages, new chronic vascular
complications of these hemoglobinopathies develop.
PH Clinicians & Researchers and PH Resource Network
(PDF)
Notes
Editorial Advisory
Board
Editor-in-Chief Richard Channick, MD
Professor of Clinical Medicine
Pulmonary and Critical Care Division
University of California, San Diego Medical Center
San Diego, California
Immediate Past Editor Ronald J. Oudiz, MD
Associate Professor of Medicine
The David Geffen School of Medicine at UCLA
Director, Liu Center for Pulmonary Hypertension
LA Biomedical Research Institute at Harbor-UCLA Medical Center
Editor-in-Chief Elect Erika Berman Rosenzweig, MD
Director, Pulmonary
Hypertension Center, Columbia University Medical Center Associate
Professor of Clinical Pediatrics (in Medicine)
Associate Editors
Kristin Highland, MD
Assistant Professor of Medicine
Division of Pulmonary, Critical Care, Allergy and Sleep Medicine
Medical University Of Carolina
Francisco Soto, MD, MS
Director, Pulmonary Hypertension Program
Pulmonary and Critical Care Medicine
Medical College of Wisconsin
Todd Bull, MD
Associate Professor of Medicine
Division of Pulmonary Sciences and Critical Care Medicine
University of Colorado Health Sciences Center
Robert Schilz, DO, PhD
Medical Director of Lung
Transplantation and Pulmonary Vascular Disease
University Hospital of Cleveland
Case Western Reserve University
Cleveland, Ohio
Publisher
Pulmonary Hypertension Association
Carl Hicks, Board Chair
Rino Aldrighetti, President
Sherrie Borden, Vice President, Medical and Patient Education
Publishing Staff Managing Editor
Deborah L. McBride
McBride Strategic Services
mcbridedeb@aol.com
P: 773-348-5455
C: 312-307-5455
Design Director
Michael McClain
Advances in Pulmonary Hypertension is circulated to
cardiologists, pulmonologists, rheumatologists and other selected
physicians by the Pulmonary Hypertension Association. The contents of the articles are independently determined by the Editor
and the Editorial Advisory Board.
Editorial Mission Advances in Pulmonary Hypertension is committed
to help physicians in their clinical decision
making by informing them of important
trends affecting their practice. Analyzing the
impact of new findings and covering current
information in the peer-reviewed literature,
Advances in Pulmonary Hypertension is published
four times a year. Advances in Pulmonary
Hypertension is the official journal
of the Pulmonary Hypertension Association.
Each article in this journal has been reviewed
and approved by members of the Editorial
Advisory Board.
Editorial Board
Charles Burger, MD
Medical Director, PH Clinic
Mayo Clinic
Jacksonville, FL
Karen Fagan, M.D. Chief, Division of Pulmonary and Critical Care Medicine University of South Alabama
Eli Gabbay, MD
Lung Transplant Unit
Royal Perth Hospital
Nick Kim, M.D.
Associate Clinical Professor of Medicine
University of California San Diego
Deborah Jo Levine, M.D.
University of Texas Health Science Center at San Antonio
San Antonio, TX
Omar Minai, MD
Dept of Pulmonary, Allergy and Critical Care Medicine
Myung Park, MD
Associate Professor of Medicine
Division of Pulmonary Sciences and Critical Care Medicine
University of Colorado Health Sciences Center
Fernando Torres, MD Director Pulmonary Hypertension Clinic
UTSW Medical Center Dallas
University Hospital
Glenna Traiger, RN, MSN
Pulmonary & Critical Care
Pulmonary Hypertension CNS
University of California Los Angeles
Los Angeles, CA
R. James White, MD, PhD
Assistant Professor of Medicine, Pharmacology & Physiology
University of Rochester, Division of Pulmonary and CCM
Roham Zamanian, MD
Division of Pulmonary and Critical Care Medicine
Stanford University Medical Center
The
information provided on the PHA website is provided for general information
only. It is not intended as legal, medical or other professional
advice, and should not be relied upon as a substitute for consultations
with qualified professionals who are familiar with your individual
needs.
It is with great pleasure that I assume the position of Editor-in-Chief of Advances in Pulmonary Hypertension. The journal is
now in its 6th year of helping physicians by informing them of
important trends in caring for patients with pulmonary hypertension.
For the past 2 years, Vallerie V. McLaughlin, MD, as
Editor-in-Chief in 2005 and 2006, has shown me how to
orchestrate the journal into a state-of-the art reference for
pulmonary hypertension that has become a stunning success,
with a circulation that has grown to more than 36,000. From her timely topic
selections to her meticulous, watchful eye, Dr McLaughlin has set the stage for
the journal’s continued success and has provided us with healthy momentum
to this end. An enormous credit goes to the journal’s founding editor, Victor F.
Tapson, MD. Dr Tapson’s efforts in launching a journal with critical reviews of
the newest areas of diagnosis and treatments for patients with pulmonary
hypertension heralded a successful 3-year tenure, a tradition that continues
today.
